Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive tumors known, with an overall 5-year survival rate of less than 6% due to early local invasion and distant metastasis. Exploring suitable therapeutic targets associated with invasion and metastasis is required for improving the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xinlu, Tan, Xiaodong, Liu, Peng, Wu, Yunhao, Qian, Songying, Zhang, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844743/
https://www.ncbi.nlm.nih.gov/pubmed/29386088
http://dx.doi.org/10.3727/096504018X15166223632406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844743/
https://www.ncbi.nlm.nih.gov/pubmed/29386088
http://dx.doi.org/10.3727/096504018X15166223632406

Ejemplares similares